Gero von Gersdorff

Publication Activity (10 Years)

Years Active: 2021-2023
Publications (10 Years): 3

Top Topics

Chronic Kidney Disease

Top Venues

Methods and protocols

JMIR research protocols

Pharmacoepidemiology and drug safety

This page only lists publications with an associated author ORCID identifier.

Publications

Sibylle C Mellinghoff, Gero von Gersdorff, Caroline Bruns, Kerstin Albus, Vassiliki Dimitriou, Angela Steinbach, Mathias Schaller, Jörg Janne Vehreschild, Oliver Andreas Cornely, Blasius Janusch Liss
Duration of Protection From Pneumonia After Pneumococcal Vaccination in Hemodialysis Patients (DOPPIO): Protocol for a Prospective Multicenter Study. JMIR research protocols 12 (2023)
Joan Fortuny, Gero von Gersdorff, Régis Lassalle, Marie Linder, Jetty A Overbeek, Jonas Reinold, Gunnar Toft, Antje Timmer, Jochen Dress, Patrick Blin, Cécile Droz-Perroteau, Vera Ehrenstein, Carla Franzoni, Ron M C Herings, Bianca Kollhorst, Nicholas Moore, Ingvild Odsbu, Susanna Perez-Gutthann, Cristina Rebordosa, Katherine Rascher, Lawrence Rasouliyan, Kenneth J Rothman, Nuria Saigi-Morgui, Mathias Schaller, Elisabeth Smits, Michael Forstner, null null, Jacques Benichou, Andreas J Bircher, Edeltraut Garbe, David S Rampton, Lia Gutiérrez
Use of intravenous iron and risk of anaphylaxis: A multinational observational post-authorisation safety study in Europe. Pharmacoepidemiology and drug safety 30 (10) (2021)
Gero von Gersdorff, Pia von Korn, André Duvinage, Gabriele Ihorst, Anika Josef, Margit Kaufmann, Thomas Baer, Tim Fellerhoff, Iris Fuhrmann, Elisa Koesel, Sven Zeissler, Lars Bobka, Marion Heinrich, Anette Schindler, Rasmus Weber, Cornelia Breuer, Anna Maria Meyer, Maria Cristina Polidori, Sophia M T Dinges, Julia Schoenfeld, Mathias Siebenbuerger, Stefan Degenhardt, Kirsten Anding-Rost, Martin Halle
Cluster Randomized Controlled Trial on the Effects of 12 Months of Combined Exercise Training during Hemodialysis in Patients with Chronic Kidney Disease-Study Protocol of the Dialysis Training Therapy (DiaTT) Trial. Methods and protocols 4 (3) (2021)